Pfizer has entered a multi-year collaboration with GSK for the development of a next-gen equipment design, based on Pfizer’s existing portable, continuous, miniature and modular (PCMM) prototype for oral solid dose (OSD) pharmaceutical development and manufacturing. Pfizer’s current PCMM prototype is an autonomous and transportable pod that can be shipped from location to location and readily brought online to create a fully functional module that is GMP compliant. Together with GSK, Pfizer wi...